Peripheral Vascular Disease
📧 Sign up to get email alerts when something new happens for Peripheral Vascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes
This trial evaluated diagnostic methods for confirming peripheral arterial disease and determining severity in diabetic patients; results ha…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Far Red Light to Improve Functioning in PAD [NA]
A clinical trial is currently recruiting to evaluate far-red light therapy for improving function in peripheral artery disease.
-
EMA approval · 2025-08-26EMA Authorised: Iscover (clopidogrel) — Sanofi Winthrop Industrie
The European Medicines Agency has authorised Iscover, a clopidogrel product from Sanofi Winthrop Industrie, for preventing thrombotic events…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: BOLT Lithotripsy RESTORE BTK Trial [NA]
The RESTORE BTK trial evaluating BOLT Lithotripsy by Bolt Medical for peripheral arterial disease has completed.
-
EMA approval · 2025-07-14EMA Authorised: Plavix (clopidogrel hydrogen sulfate) — Sanofi Winthrop Industrie
The EMA authorised Plavix (clopidogrel hydrogen sulfate) for use with indications including stroke, peripheral vascular disease, atrial fibr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Clinical Outcomes, Safety, and Cost-Effectiveness Analysis of Two Catheters (Xianrui Da and Medtronic) in Radiofrequency Ablation for Varicose Veins [NA]
A clinical trial update describing outcomes, safety, and cost-effectiveness analyses of two radiofrequency ablation catheters (Xianrui Da an…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: GLYCAR Post Market Multicenter Study
GLYCAR's post-market multicenter study update indicates the trial is currently ACTIVE_NOT_RECRUITING. It involves congenital heart disease a…
-
EMA approval · 2025-06-23EMA Authorised: Grepid (clopidogrel (as besilate)) — Pharmathen S.A.
EMA authorised the drug Grepid, containing clopidogrel besilate, for indications including peripheral vascular diseases, stroke, and myocard…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI) [Phase 1, Phase 2]
This clinical trial update reports that BioGenCell's BGC101 (EnEPC) autologous cell therapy is being studied for critical limb ischemia in P…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: MSOT_PI Analysis of Revascularization Procedure Using Optoacoustic Imaging
A completed clinical trial evaluating optoacoustic imaging (MSOT_PI) to analyze revascularization procedures in peripheral artery disease.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Weight Off-loading Training, Cardiovascular Indices, Diabetes [NA]
A completed clinical trial from Umm Al-Qura University evaluating weight off-loading training and its effects on cardiovascular indices and …
-
EMA approval · 2025-05-14EMA Authorised: Zyllt (clopidogrel (as hydrogen sulfate)) — Krka, d.d., Novo mesto
EMA authorised Zyllt, a clopidogrel hydrogen sulfate product by Krka, d.d., Novo mesto. It is indicated for preventing vascular events in pa…
-
EMA approval · 2025-05-13EMA Authorised: Clopidogrel Krka d.d. (previously Zopya) (clopidogrel (as hydrochloride)) — Norpharm Regulatory Services Ltd
The EMA authorised Clopidogrel Krka d.d. for indications including peripheral vascular disease, stroke, and myocardial infarction; the marke…
-
EMA approval · 2025-05-13EMA Authorised: Clopidogrel TAD (clopidogrel (as hydrochloride)) — Tad Pharma GmbH
EMA authorised Clopidogrel TAD (clopidogrel hydrochloride) by Tad Pharma GmbH for use in peripheral vascular diseases, stroke, and myocardia…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: The Mechanical Characterisation of Human Saphenous and Popliteal Vein
This clinical trial update describes a study assessing the mechanical properties of human saphenous and popliteal veins. It is currently rec…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Early Discovery of Ischemia After Replantation Surgery of the Extremities [NA]
A clinical trial led by Oslo University Hospital is investigating early detection of ischemia after limb replantation surgery and is current…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization [Phase 4]
Phase 4 trial assessing the incidence of venous thromboembolism after rivaroxaban plus aspirin versus single antiplatelet therapy following …
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Prospective and Non-randomized Registry of CardioCel 3D
Clinical trial registry update for CardioCel 3D by LeMaitre Vascular, describing a prospective, non-randomized registry for intracardiac and…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair [NA]
This clinical trial update describes evaluating the safety and effectiveness of the XenoSure Biological Patch for peripheral vascular repair…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: The Effect of Ischemic Conditioning on Strength and Ambulation in Subjects with PAD [NA]
This clinical trial update describes a completed study evaluating whether ischemic conditioning improves strength and ambulation in people w…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) [NA]
University of Washington completed Trial 2 of a hospital-based program to improve communication about serious illness; results have been pos…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: BOLT Lithotripsy RESTORE ATK Trial [NA]
The RESTORE ATK trial of BOLT Lithotripsy has completed according to sponsor Bolt Medical. The trial targeted Peripheral Arterial Disease an…
-
CLINICAL_TRIALS other · 2025-01-28Clinical Trial Update: Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty. [NA]
Clinical trial NCT05153421 evaluating All'InCath for peripheral vascular angioplasty has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Onco-Vascular Exer-Study [NA]
The update notes the completion of the Onco-Vascular Exer-Study (NCT06766903) sponsored by Cristian Alvarez, involving breast cancer and sev…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: The Influences of Single Chamber Vs. Multi-chamber Blood Flow Restriction Cuffs with Bicep Curls [NA]
The trial comparing single-chamber versus multi-chamber blood flow restriction cuffs during bicep curls has completed.